National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 66320-66321 [2021-25335]
Download as PDF
<![CDATA[
66320
Federal Register / Vol. 86, No. 222 / Monday, November 22, 2021 / Notices
Reduction Act of 1995 to provide
opportunity for public comment on
proposed data collection projects, the
National Institutes of Health (NIH),
Office of Research Services (ORS),
Division of Occupational Health and
Safety (DOHS) will publish periodic
summaries of proposed projects to be
submitted to the Office of Management
and Budget (OMB) for review and
approval.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 60 days of the date of this
publication.
FOR FURTHER INFORMATION CONTACT: To
obtain a copy of the data collection
plans and instruments, submit
comments in writing, or request more
information on the proposed project,
contact: Dr. Jessica McCormick-Ell,
Ph.D., SM (NRCM), CBSP, RBP, NIH/
ORS/SR/DOHS, Bldg. 13/3W80,
Bethesda, MD 20892–5760 or call nontoll-free number (301) 496–0590 or
Email your request, including your
address to: jessica.mccormick-ell@
nih.gov. Formal requests for additional
plans and instruments must be
requested in writing.
Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 requires: Written
comments and/or suggestions from the
public and affected agencies are invited
to address one or more of the following
points: (1) Whether the proposed
collection of information is necessary
for the proper performance of the
function of the agency, including
whether the information will have
practical utility; (2) The accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
Ways to enhance the quality, utility, and
clarity of the information to be
collected; and (4) Ways to minimizes
the burden of the collection of
information on those who are to
respond, including the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
Proposed Collection Title: NIH
COVID–19 Vaccination Status Form
EXTENSION, 0925–0771, exp., 3/31/
2022, Office of Research Services (ORS),
National Institutes of Health (NIH).
SUPPLEMENTARY INFORMATION:
Need and Use of Information
Collection: The purpose of the NIH
COVID–19 Vaccination Status Form is
to ensure the safety of the Federal
workplace consistent with Executive
Order 14042 Ensuring Adequate COVID
Safety Protocols for Federal Contractors,
Executive Order 14043 Requiring
Coronavirus Disease 2019 Vaccination
for Federal Employees, the COVID–19
Workplace Safety: Agency Model Safety
Principles established by the Safer
Federal Workforce Task Force, and
guidance from the Centers for Disease
Control and Prevention (CDC) and the
Occupational Safety and Health
Administration (OSHA). The proposed
information collection will be used to
ensure compliance with vaccination
requirements in the authorities above,
generate the list of persons required to
be tested on a routine basis, and will
provide important information
regarding safety frameworks, guidance,
and procedures.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
2,583.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondent
Average time
per response
(in hours)
Total annual
burden hour
Certified nurse coaches .................................................................................
31,000
1
5/60
2,583
Total ........................................................................................................
........................
31,000
........................
2,583
Dated: November 16, 2021.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes
of Health.
[FR Doc. 2021–25412 Filed 11–19–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
jspears on DSK121TN23PROD with NOTICES1
Number of
responses per
respondent
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
VerDate Sep<11>2014
18:30 Nov 19, 2021
Jkt 256001
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Computational, Modeling, and
Biodata Management.
Date: December 3, 2021.
Time: 2:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Marie-Jose Belanger, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Rm. 6188,
MSC 7804, Bethesda, MD 20892, (301) 435–
1267, belangerm@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
Dated: November 17, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
[FR Doc. 2021–25386 Filed 11–19–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
E:\FR\FM\22NON1.SGM
22NON1
66321
Federal Register / Vol. 86, No. 222 / Monday, November 22, 2021 / Notices
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Microbiology,
Infectious Diseases and AIDS Initial Review
Group; Acquired Immunodeficiency
Syndrome Research Study Section.
Date: December 13, 2021.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3F40A,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Dimitrios Nikolaos
Vatakis, Ph.D., Scientific Review Officer,
Scientific Review Program, Division of
Extramural Activities, National Institute of
Allergy and Infectious Diseases, National
Institutes of Health, 5601 Fishers Lane, MSC–
9823, Bethesda, MD 20892, (301) 761–7176,
dimitrios.vatakis@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: November 16, 2021.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–25335 Filed 11–19–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request; Federal COVID
Response—Audience Feedback To
Inform Ongoing Messaging and
Strategies for ‘‘Combat COVID’’
AGENCY:
National Institutes of Health,
HHS.
ACTION:
approval of the information collection
listed below.
Proposed Collection: Audience
Feedback to Inform Ongoing Messaging
and Strategies for ‘‘Combat COVID,’’
OMB #0925–0769, exp., date 12/31/
2021, EXTENSION National Institutes of
Health (NIH).
Need and Use of Information
Collection: The purpose of the
information collection is to collect
routine feedback from the Combat
COVID Initiative’s two target audiences
(the general public and healthcare
providers) to identify evolving needs
and better disseminate relevant
information as it relates to COVID–19
treatment and Accelerating COVID–19
Therapeutic Interventions and Vaccines
(ACTIV) clinical trial resources,
specifically. Data collected will be used
to inform the development and broad
dissemination of Combat COVID
resources, including new or enhanced
message and material concepts (e.g.,
social media ads, digital display ads,
out-of-home ads), and/or web pages
(combatcovid.hhs.gov). Because the
COVID–19 treatment landscape
continues to evolve, new evidencebased information continues to come to
the forefront, and audience needs
continue to change, it is critical for the
Federal COVID Response (FCR) Team to
collect quick audience feedback from
the general public (especially from
groups who have not historically been
well-represented in clinical trials) and
healthcare providers to identify these
evolving needs. By understanding target
audience needs, the FCR team will be
able to properly develop and broadly
disseminate relevant COVID–19
treatment and ACTIV clinical trial
resources. A change request was
recently submitted to update the recall
stimuli (still images, audio, and video or
animated images) for questions about
exposure to the Combat COVID message
and materials. It also removed questions
that are no longer relevant and replaced
them with more relevant questions
about the latest COVID–19 treatment
options and clinical trials.
OMB approval is requested for 1 year.
There are no costs to respondents other
than their time. The total estimated
annualized burden hours are 3,528.
Notice.
In compliance with the
Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has
submitted to the Office of Management
and Budget (OMB) a request for review
and approval of the information
collection listed below.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 30-days of the date of this
publication.
SUMMARY:
Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact: Ms. Mikia P.
Currie, Office of Policy for Extramural
Research Administration, 6705
Rockledge Drive, Suite 350, Bethesda,
Maryland 20892, or call a non-toll-free
number (301) 435–0941 or Email your
request, including your address to:
ProjectClearanceBranch@mail.nih.gov.
SUPPLEMENTARY INFORMATION: This
proposed information collection was
previously published in the Federal
Register on September 7, 2021, page
50143 (86 FR 50143) and allowed 60
days for public comment. No public
comments were received. The purpose
of this notice is to allow an additional
30 days for public comment. The
National Institutes of Health may not
conduct or sponsor, and the respondent
is not required to respond to, any
information collection that has been
extended, revised, or implemented on or
after October 1, 1995, unless it displays
a currently valid OMB control number.
In compliance with Section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
ADDRESSES:
jspears on DSK121TN23PROD with NOTICES1
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Form name
Consumer Audience Feedback Team Screener .............................................
HCP Audience Feedback Team Screener ......................................................
Consumer Audience Feedback Activity ...........................................................
HCP Audience Feedback Activity ....................................................................
VerDate Sep<11>2014
18:30 Nov 19, 2021
Jkt 256001
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
120
40
60
20
E:\FR\FM\22NON1.SGM
1
1
8
8
22NON1
Average time
per response
(in hours)
5/60
5/60
1
1
Total annual
burden hours
10
3
480
160
]]>Agencies
[Federal Register Volume 86, Number 222 (Monday, November 22, 2021)]
[Notices]
[Pages 66320-66321]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-25335]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
[[Page 66321]]
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Microbiology, Infectious Diseases and AIDS
Initial Review Group; Acquired Immunodeficiency Syndrome Research
Study Section.
Date: December 13, 2021.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3F40A,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Dimitrios Nikolaos Vatakis, Ph.D., Scientific
Review Officer, Scientific Review Program, Division of Extramural
Activities, National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, MSC-9823,
Bethesda, MD 20892, (301) 761-7176, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: November 16, 2021.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-25335 Filed 11-19-21; 8:45 am]
BILLING CODE 4140-01-P
